European specialist investor Global Healthcare Opportunities, also called GHO Capital Partners, recently announced that it has acquired Ardena — a specialist contract development and manufacturing organization focused on early phase drug development.
Financial terms of the deal, announced Jan. 9, were not disclosed.
Get the full story on sister site Drug Discovery and Development.